CDT Equity CDT
NASDAQ CDT
$1.36 -0.09 (-6.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

CDT Equity (CDT) Receivables - Net (2024)

Updated

CDT Equity (CDT) reported Receivables - Net of $525,000 for Q3 2024.

Analysis

CDT Equity (CDT) Receivables - Net (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 CDT Equity 36,602.35 36,602.35 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 525,000.00
API Access

CDT Equity Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=CDT&period=max&api_key=YOUR_API_KEY